Medicines Development For Global Health

This large study compared the safety of a newer drug called moxidectin against the standard drug ivermectin for treating river blindness. It involved nearly 13,000 people aged 4 and older living in areas where the disease is common. Some participants also received an additional d…

This study aimed to find the right dose of the medication moxidectin for children aged 4 to 11 years to treat river blindness (onchocerciasis). Researchers tested a single oral dose in 36 children and teenagers in Ghana to see how their bodies processed the drug and to check for …